A similar pattern emerged from analysis CAR activities over the time course of infection (Figure 3 Bottom, E:T of 0.04:1); the bispecific CD4-R5Nt CAR was significantly more potent than the CD4 monospecific CAR, approaching the efficacy of the CD4-MBL CAR. The gene discussed is CD4; the disease is infection.